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Background/Aims
Guanine nucleotide binding protein (G-protein) beta polypeptide 3 (GNB3) C825T polymorphism alters intracellular signal trans-
duction, which may lead to motor or sensory abnormalities of the gastrointestinal tract. The aim of the present study was to 
evaluate the association of the GNB3 C825T polymorphism with susceptibility to overlap syndrome of functional dyspepsia (FD) 
and irritable bowel syndrome (IBS) in a Korean population.
Methods
One hundred sixty-seven patients with FD alone, 60 patients with IBS alone, 85 patients with the overlap of FD and IBS, and 
434 asymptomatic healthy subjects participated in the study. Genotyping for GNB3 C825T polymorphism was performed using 
their blood samples. 
Results
No association of GNB3 genotypes in patients with FD alone, IBS alone or overlap phenotype, when compared to genotypes 
in controls, was detected. The frequency of CT and TT genotypes relative to the CC genotype for the phenotypes of FD alone, 
IBS alone and the coexistence of FD and IBS did not significantly differ. Comparison of the TT genotype with the CC/CT geno-
type showed no significant association for each phenotype group.
Conclusions
There is no apparent association of the GNB3 C825T polymorphism with the susceptibility to FD, IBS or the overlap of FD and 
IBS. Larger-scale studies and further investigation on other candidate genes are required. 
(J Neurogastroenterol Motil 2012;18:205-210)
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Introduction
Familial aggregation of patients with functional gastrointes-
tinal disorders indicates that susceptibility to functional gastro-
intestinal disorders may be influenced by hereditary factors.
1 
Genetic variations of potential modulators of gastrointestinal sen-
sory and motor function appear to influence the genesis of symp-
toms in patients with functional gastrointestinal disorders. There 
are twin studies that have shown that identical twins will have a 
greater concordance of having IBS than dizygotic twins, suggest-
ing that genetic factors may contribute to the pathogenesis of 
IBS.
2 However, the susceptibility genes for functional gastro-
intestinal disorders are unknown yet and remain to be identified. 
Guanine nucleotide binding protein (G-protein) beta poly-
peptide 3 (GNB3) gene is known to be associated with FD or 
IBS. A common C825T polymorphism has been described in the 
gene GNB3 that encodes the beta3 subunit of heterotrimeric 
G-proteins. This polymorphism gives rise to 3 possible genotypes 
(C/C, T/C and T/T). The 825T allele of the T/C or T/T geno-
type is associated with alternative splicing of the gene and the for-
mation of a truncated but functionally active splice variant. 
Studies on the genetic variation associated with FD and IBS have 
produced inconsistent results, which is probably attributable to a 
complex multi-factorial pathophysiology and ethnic differences. 
For example, the C/C genotype of C825T polymorphism is asso-
ciated with unexplained dyspepsia in Germany.
3 Whereas, homo-
zygous T or C alleles of the GNB3 C825T polymorphism is as-
sociated with meal-unrelated dyspepsia in a United States (US) 
community.
4 Tertiary referral FD in the Netherlands and dys-
pepsia in the Helicobacter pylori-negative Japanese population are 
reported to be associated with the 825T allele of the GNB3 
gene.
5,6 GNB3 C825T polymorphism is not associated with low-
er functional gastrointestinal disorders.
7
The 825T allele is believed to be associated with enhanced 
G-protein activation and, thereby, increased cellular or physio-
logic responses.
8 Homozygous 825C allele carriers (C/C geno-
type) are characterized by diminished signal transduction 
responses. Evidence shows that the GNB3 status is associated 
with depression,
9 increased immune cell activation
10 and altered 
activation of α2-adrenoceptors.
8 A diminished or increased sig-
nal transduction response could lead to motor or sensory abnor-
malities of the gastrointestinal tract that can be pathophysiologic 
mechanisms underlying FD and IBS.
11 FD and IBS are highly 
prevalent diseases comprising 10% to 25% of the general popula-
tion.
12 These 2 conditions commonly coexist.
13,14 Clinical studies 
regarding the pathophysiology of FD and IBS have identified a 
number of functional abnormalities including disturbances in 
gastrointestinal motor and sensory function.
15-18 The symptom 
pattern and underlying pathophysiological mechanisms may be 
different between patients with FD alone compared to patients 
with both FD and IBS. It has been reported that patients with 
FD and IBS do not differ in the prevalence of delayed gastric 
emptying or of impaired gastric accommodation to a meal, but 
have a greater prevalence of hypersensitivity to gastric dis-
tension.
19 Thus, we hypothesized that GNB3 C825T poly-
morphism, particularly 825T allele, is more likely to be associated 
with the overlap of FD and IBS rather than FD alone or IBS 
alone. In the present study, we aimed to study the association of 
the GNB3 C825T polymorphism with susceptibility to FD 
alone, IBS alone and the overlap of FD and IBS in a Korean 
population.
Materials and Methods
Study Subjects
Patient cases and control subjects of the study were recruited 
between January 2007 and December 2008 from visitors to 
Department of Gastroenterology and the Health Promotion 
Center of Ajou University Hospital. Subjects without symptoms 
who visited for health check-up were recruited as healthy con-
trols, and patients with recurrent abdominal symptoms were re-
cruited as patient cases. They underwent examinations including 
endoscopy, excluded organic causes, and completed a self-ad-
ministered questionnaire for the diagnosis of FD and IBS ac-
cording to the ROME III criteria.
20 All subjects were Koreans. 
One hundred sixty-seven patients with FD alone, 60 patients 
with IBS alone, 85 patients with the overlap of FD and IBS and 
434 asymptomatic healthy subjects participated in the study. 
They allowed the use of their blood for the present study. This 
study was approved by the institutional review board of Ajou 
University Hospital and written informed consent was obtained 
from all participants.
Questionnaire
The questionnaire included information on demographics 
and Rome III criteria for the diagnosis of FD and IBS. 
Dyspeptic symptoms were defined as pain or discomfort in the 
upper abdomen for the last 3 months, with symptom onset at least GNB3 Polymorphism and Overlap Syndrome
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Table 1. Demographics and Genotype Distribution in Subjects With Functional Dyspepsia Alone, Asymptomatic Controls, Irritable Bowel
Syndrome Alone and the Overlap of Functional Dyspepsia and Irritable Bowel Syndrome
Group
a
Controls FD IBS Overlap
Gender (M:F [n])   167:267     62:105   25:35   30:55
Mean age (± SD), yr   47 (± 15)   49 (± 15) 43 (± 12) 44 (± 15)
GNB3 C825T Genotype (n [%])
    CC 112 (25.8)   52 (31.1) 16 (26.7) 16 (18.8)
    CT 215 (49.5)   76 (45.5) 31 (51.7) 42 (49.4)
    TT 107 (24.7)   39 (23.4) 13 (21.7) 27 (31.8)
    Total  434 167 60 85
aFD: functional dyspepsia alone, Controls: asymptomatic controls, IBS: irritable bowel syndrome alone, Overlap: coexistence of functional dyspepsia and irritable bowel
syndrome.
GNB3, guanine nucleotide binding protein beta polypeptide 3.
6 months prior to the check-up. IBS was defined as recurrent ab-
dominal pain or discomfort at least 3 days per month in the last 3 
months associated with 2 or more of the following: improvement 
with defecation, onset associated with a change in stool frequency, 
or onset associated with a change in stool form.
Genotyping
The blood samples were stored at -80
oC until use. Genomic 
DNA was isolated from whole blood using G-DEX
TM blood ge-
nomic DNA purification kits (Intron Biotechnology Inc., 
Seongnam, Korea) and quantified using the Picogreen dsDNA 
quantification reagent according to the standard protocol 
(Molecular Probes, Eugene, OR, USA). Genotyping was per-
formed using TaqMan Pre-Designed single nucleotide poly-
morphism (SNP) Genotyping Assay (Applied Biosystems, 
Foster City, CA, USA). The allelic discrimination of SNPs on 
the basis of the TaqMan technology was performed. Fluore-
scence is released while the target fragment is amplified by the se-
quence detection primers. PCR is performed in standard PCR 
machines and in a real time PCR machine. This platform is par-
ticularly well suited for the analysis of a large number of samples 
with a moderate number of SNPs.
Statistical Methods
We presumed that a 10% increase in the prevalence of a gen-
otype would be of clinical relevance. Assuming that a level of sig-
nificance is 5% (α = 0.05) and a power is 80% (β = 0.80), a 
sample of 329 patients and 329 healthy controls would be suffi-
cient to reveal clinically relevant differences. PASS 2008 software 
(NCSS, Kaysville, Utah, USA) was used for the calculation of 
sample size. Deviations from the Hardy-Weinberg equilibrium 
were checked using chi-square tests. We compared GNB3 geno-
types in patients with FD alone, IBS alone and the overlap of FD 
and IBS vs asymptomatic controls. The calculation of the odds 
ratio (OR), 95% confidence intervals (CI) and P-values were 
performed using a multiple logistic regression model after con-
trolling for age and gender as covariates. The P-value threshold 
for statistical significance used in this study was 0.05. SAS stat-
istical software (SAS 9.1 and SAS Enterprise Guide 4.1; SAS 
Institute, Cary, NC, USA) was used for the statistical analysis. A 
P ＜ 0.05 was considered significant.
Results
Participant demographics and GNB3 C825T genotype dis-
tribution are summarized in Table 1. No significant difference 
was found between the groups for gender and age. The GNB3 
genotype distribution in all study subjects was 196 CC (26.3%), 
364 CT (48.8%) and 186 TT (24.9%). This distribution did not 
deviate from those expected under the Hardy-Weinberg equili-
brium (P ＞ 0.05). The distribution of allele and genotype fre-
quencies did not differ significantly between males and females.
Table 2 shows the results of logistic regression analysis ad-
justed for age and sex on the association of genotype with each 
group, compared with asymptomatic controls. No association of 
genotype in subjects with FD alone, IBS alone or overlap pheno-
type compared to that in controls was detected (P ＞ 0.05). The 
OR for the co-dominant, dominant and recessive models are 
shown in Table 2. The frequency of GNB3 C825T CT and TT 
genotypes relative to the CC genotype for the phenotypes of FD 
alone, IBS alone, and the overlap of FD and IBS did not sig-
nificantly differ. Comparison of the TT genotype with the Han Gyeol Kim, et al
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Table 2. Logistic Regression Analysis Adjusted for Age and Sex in Subjects With Functional Dyspepsia Alone, Asymptomatic Controls, 
Irritable Bowel Syndrome Alone and the Overlap of Functional Dyspepsia and Irritable Bowel Syndrome
Model
FD
a vs Controls
b IBS
c vs Controls Overlap
d vs Controls
P-value  OR (95% CI) P-value OR (95% CI) P-value OR (95% CI)
Co-dominant 0.329 1.13 (0.88-1.46) 0.723 0.93 (0.63-1.37) 0.112 1.31 (0.94-1.83)
Dominant 0.718 1.04 (0.84-1.28) 0.671 0.93 (0.67-1.29) 0.160 1.21 (0.93-1.55)
Recessive 0.220 1.13 (0.93-1.38) 0.874 0.97 (0.72-1.33) 0.234 1.19 (0.89-1.61)
MAF 0.321 1.07 (0.94-1.21) 0.723 0.97 (0.79-1.17) 0.112 1.14 (0.97-1.35)
aFD: functional dyspepsia alone, 
bControls: asymptomatic controls, 
cIBS: irritable bowel syndrome alone, 
dOverlap: coexistence of functional dyspepsia and irritable 
bowel syndrome.
Co-dominant, CC vs CT vs TT; Dominant, CC vs CT and TT; Recessive, CC and CT vs TT; MAF, minor allele frequency.
CC/CT genotype showed no significant association for each phe-
notype group.
Discussion
This study evaluated GNB3 C825T polymorphism in a 
Korean population comprising people with FD alone, IBS alone, 
the overlap of FD and IBS, and healthy controls who visited out-
patient clinic for abdominal symptoms or a health care unit for 
annual health check-up. We failed to demonstrate an association 
between GNB3 C825T polymorphism and the overlap of FD 
and IBS. Furthermore, no significant association between GNB3 
C825T polymorphism and the existence of FD alone or IBS 
alone was found in the present study. Our findings are consistent 
with a previous study from a Korean population.
21 In contrast, 
data from Japan show that homozygous GNB3 825T is asso-
ciated with Japanese dyspeptic subjects without H. pylori in-
fection or with epigastric pain syndrome-like symptomatology.
6,22 
We explored whether any subgroup of FD or IBS is different 
from controls since the subgroups of these syndromes are likely to 
have different pathogenesis and may confound the results. 
However, we did not find any association of homozygous GNB3 
825T with epigastric pain syndrome-like dyspepsia, postprandial 
distress syndrome-like dyspepsia, IBS with diarrhea or IBS with 
constipation (data not shown).
Similarly, in the West, conflicting results have been reported. 
While a study from the Netherlands demonstrated that T allele 
carriers of GNB3 C825T polymorphism are associated with dys-
pepsia,
5 a report in a German population shows that homozygous 
GNB3 825C status is associated with unexplained dyspepsia.
3 
Furthermore, reports from the US revealed that meal-unrelated 
dyspepsia is associated with both the homozygous GNB3 825T 
and C genotypes.
4 These contrasting observations may be parti-
ally explained by a racial difference and heterogeneity of the 
disease. In addition, the diagnostic criteria of FD, sample se-
lection or sample size may affect the outcome. T alleles of the 
GNB3 C825T polymorphism are reported to be more strongly 
correlated with IBS with constipation in the Korean population.
23 
The study population included 88 control cases and 12 con-
stipation predominant IBS cases. This sample size does not ap-
pear to be adequate for the study on the association of GNB3 
C825T polymorphism with disease susceptibility. Moreover, 
there is a contradictory study showing that GNB3 C825T poly-
morphism is not associated with FD and IBS in Koreans.
21 The 
study population consisted of 70 healthy controls, 62 FD patients 
and 49 IBS patients. The number of this study population ap-
pears to be too small to show the association of genetic poly-
morphisms with disease susceptibility. Relatively small sample 
sizes may produce the type II error. The sample size of the pres-
ent study is greater than that of the previous Korean studies. 
Based on the results of the sample size calculation that 224 pa-
tients and 448 healthy controls were required, we recruited 312 
patients and 434 healthy controls in the present study. However, 
the number of each group, particularly the number of each sub-
group, might be not sufficient.
Disturbed gut sensory or motor function, dysfunction of the 
autonomic nervous system, and underlying psychiatric dis-
turbance have been suggested to contribute to the pathophysiol-
ogy of functional gastrointestinal disorders like FD and IBS.
15-19 
All of these abnormalities may be associated with the alteration of 
intracellular signal transduction. Approximately up to 80% of all 
known membrane receptors that are linked to intracellular effec-
tor systems are coupled to G-proteins.
8,10 G-proteins play a cru-
cial role in intracellular signal transduction. Therefore, qual-
itative or quantitative changes in G-proteins may lead to func-
tional changes by inhibiting or enhancing intracellular signal GNB3 Polymorphism and Overlap Syndrome
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transduction. The GNB3 gene encodes the β3 subunit of hetero-
trimeric G-proteins, which is known to potentially affect intra-
cellular signal transduction and biological activity, and the 825T 
is associated with enhanced G-protein activation.
24 Given that pa-
tients with FD and IBS do not differ in the prevalence of delayed 
gastric emptying or of impaired gastric accommodation to a meal, 
but have a greater prevalence of hypersensitivity to gastric dis-
tension,
19 GNB3 C825T polymorphism, particularly 825T allele, 
is more likely to be associated with the overlap of FD and IBS 
rather than FD alone or IBS alone. It is conceivable that the 
GNB3 genotype is involved in the generation of common patho-
physiologic mechanisms underlying FD and IBS. Transition of 
functional gastrointestinal disorders in their natural history sup-
ports our hypothesis. To my knowledge, this is the first study in-
vestigating the genetic factors of overlap syndrome. However, in 
the present study, we failed to find the association of the GNB3 
polymorphism with the overlap of FD and IBS. Genetic poly-
morphisms of other candidate genes warrant further investi-
gation.
The data in the present study are from outpatient clinic of the 
university hospital and from subjects undergoing health check- 
up. We selected subjects who underwent upper or lower gastro-
intestinal endoscopy in order to exclude organic causes. There-
fore, uninvestigated subjects were not included in the study. All 
subjects are Korean. Korean population is known to be genet-
ically homogenous. Although GNB3 C825T polymorphism does 
not have any statistically significant association with FD and IBS 
in the present study, this negative association might be affected by 
multiple pathophysiologic mechanisms underlying functional 
gastrointestinal disorders. 
In conclusion, our findings suggest that there is no apparent 
association of the GNB3 C825T polymorphism with the suscept-
ibility to FD, IBS or the overlap of FD and IBS. Larger-scale 
studies and further investigation on other candidate genes are 
required.
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